Secondary preventive, nurse based, telephone follow-up for reduction of cardiovascular events after acute coronary syndrome or stroke

Not Applicable

Completed

• Conditions: Acute coronary syndrome, stroke and transient ischemic attack; Circulatory System

• Registration Number: ISRCTN30433343
• Lead Sponsor: Jamtland County Council (Sweden)

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34341395/ (added 08/02/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-01-26
• Study Completion: 2020-04-06
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1833

Inclusion Criteria

1. All patients living in the county of Jämtland, Sweden, and hospitalised with a diagnosis of an acute coronary syndrome (ACS, acute myocardial infarction or unstable angina pectoris), stroke (ischemic or hemorrhagic) or transient ischemic attack (TIA) will be assessed for inclusion
1.1. Östersund hospital is the only hospital in the county and all patients, terminal care excluded, with symptoms of an ACS or suspected stroke or TIA are referred for diagnostic evaluation. A routine for identification of all patients in the hospital with a possible ACS or stroke/TIA has been established in previous studies.
2. All patients with a physical and mental capacity to communicate by telephone

Exclusion Criteria

1. Patients with severe disease
2. Aphasia
3. Dementia
4. Deafness
5. Participation in another trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Major adverse cardiovascular events identified at the end of trial by reviewing patients medical records and by the Swedish National Patient Register and the Swedish Cause of Death Register defined as:<br> 1. Non-fatal major coronary event: myocardial infarction or coronary revascularisation<br> 2. Non-fatal stroke<br> 3. Cardiovascular death<br>

Secondary Outcome Measures

Name	Time	Method
<br> Major adverse cardiovascular events identified at the end of trial by reviewing patients medical records and by the Swedish National Patient Register and the Swedish Cause of Death Register.<br> 1. Separate assessment of the individual components of the primary endpoint<br> 2. Transient ischemic attack<br> 3. All-cause mortality<br> 4. Separate assessment of the acute coronary syndrome and the stroke / TIA cohorts<br>